bell
The current prices are delayed by 15 mins, login to check live prices.
Pfizer Ltd share price logo

Pfizer Ltd

(PFIZER)

₹5131.30.91%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Pfizer Ltd Analyst Rating

based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Pfizer Ltd. An average target of ₹5935

Source: S&P Global Market Intelligence

Pfizer Ltd Share analysis

Pfizer Ltd price forecast by 3 analysts

Upside of14.61%

High

₹7175

Target

₹5935.00

Low

₹5300

Pfizer Ltd target price ₹5935, a slight upside of 14.61% compared to current price of ₹5131.3. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Pfizer Ltd Performance

  • Day's Low

    Day's High

    ₹5,100
    ₹5,210.65
  • 52 Week's Low

    52 Week's High

    ₹3,950
    ₹6,451.15
1 Month Return-7.49 %
3 Month Return-13.34 %
1 Year Return+ 28.3 %
Previous Close₹5,178.55
Open₹5,188.65
Volume10.11K
Upper Circuit-
Lower Circuit-
Market Cap₹23,690.69Cr

Pfizer Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹23,690.69 Cr
P/B Ratio5.34
EPS98.27
Dividend Yield0
SectorPharmaceuticals
ROE16.21

Pfizer Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹23,690.69 Cr5.09%0.52NANA
BUY₹14,159.53 Cr-2.2%0.52₹602 Cr₹2,851 Cr
BUY₹73,248.19 Cr38.18%0.56₹3,168 Cr₹29,001 Cr
HOLD₹95,350.73 Cr54.5%0.64₹3,854 Cr₹19,547 Cr
BUY₹57,851.74 Cr23.94%0.53NANA

About Pfizer Ltd

Pfizer Limited is a leading pharmaceutical company that has been active in India since 1950, and has built up a strong portfolio with 43 manufacturing sites in 125 countries. They have 6 primary therapeutic areas including Oncology, Hospital Vaccines, Inflammation and Immunology, and have managed to keep up with cutting-edge technology with research and clinical trials. Over the years Pfizer Limited has seen many changes, from a Merger with ParkeDavis in 2002 and the closure of a manufacturing plant at Ankleshwar in 1999 to being the first company to introduce hormone replacement therapy and conjugated pneumococcal vaccines in India. In 2015 the plant located at Thane Belapur Road Navi Mumbai was transferred to a going concern with the sale to Vidhi Research and Development LLP, and in 2017 Pfizer acquired the brand Neksium with active ingredient Esomeprazole. The Goa plant was recognized with the India Manufacturing Excellence Award-Future Ready Factory of the Year Award 2017 and the Pfizer's President's Platinum Award for 2017. Pfizer Inc. USA, the Ultimate Holding Company, completed the transaction of combining its Upjohn Business with Mylan N.V. in 2019. Currently the company earns a revenue of Rs 176 Crore (nine months period ended in 2019) for their Corex brand, with Rs 244 Crore in profit for the financial year ending in 2016. Pfizer Limited continues to innovate and grow in the Indian market.

Share Price: ₹5131.30 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹23,690.69Cr as of today
Listing date: 09 Dec, 1994
Chairperson Name: Pradip P Shah
OrganisationPfizer Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Pfizer Ltd

  • Pfizer Expands Manufacturing and R&D in India - 12 Nov, 2024

    Pfizer Limited is enhancing its manufacturing and R&D capabilities in India, shifting oncology products to Gujarat, and aiming to introduce more made-in-India products and adult vaccinations.

  • Pfizer Reports Positive Q2 Earnings Growth - 28 Oct, 2024

    Pfizer Ltd announced a 6.3% increase in net profit to ₹158 crore for Q2 2024, with revenue up 2.3% to ₹589 crore. EBITDA also showed growth, reflecting improved margins.

Insights on Pfizer Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, PFIZER stock has moved up by 4.9%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.22% to 3.54% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.32% to 10.43% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.92% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 125.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 30.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.01% to 16.50% in Sep 2024 quarter

Pfizer Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹3,305.20Cr (-)₹3,915.13Cr (↑18.45%)₹4,001.35Cr (↑2.20%)₹4,229.16Cr (↑5.69%)
Total Liabilities₹912.16Cr (-)₹1,050.72Cr (↑15.19%)₹794.05Cr (↓24.43%)₹633.62Cr (↓20.20%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹323.18Cr (-)₹427.33Cr (↑32.23%)₹667.08Cr (↑56.10%)₹355.68Cr (↓46.68%)₹256.84Cr (↓27.79%)

Index Inclusions

BSE 500

₹34,361.41

-0.84 (-289.42%)

BSE Small-Cap

₹52,141.15

-0.67 (-349.79%)

S&P BSE 400 MidSmallCap

₹11,623.42

-0.49 (-57.13%)

Nifty MidSmallcap 400

₹18,989.75

-0.45 (-86.25%)

Nifty 500

₹21,820.85

-0.83 (-183.5%)

S&P BSE 250 SmallCap

₹6,734.99

-0.72 (-48.51%)

BSE Healthcare

₹42,447.07

0.11 (46.96%)

Nifty Smallcap 250

₹16,747.85

-0.58 (-97.4%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Pfizer Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
63.92%
0.00
Foreign Institutions
3.54%
9.89
Mutual Funds
10.43%
25.33
Retail Investors
16.5%
-3.01
Others
5.61%
-25.45

Pfizer Ltd Key Indicators

Details20202021202220232024
Return On Equity %15.8917.1923.320.5516.21
Details20042005200620072008
Book Value Per Share (₹)117.53125.99135.97217.73301.97
Details20042005200620072008
Earning Per Share (₹)14.1322.332.48109.2798.27

Pfizer Ltd Earnings and Dividends

  • Pfizer Ltd Earnings Results

    Pfizer Ltd’s net profit jumped 6.3% since last year same period to ₹158.35Cr in the Q2 2024-2025. On a quarterly growth basis, Pfizer Ltd has generated 5.07% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Pfizer Ltd Dividends May,2024

    In the quarter ending March 2024, Pfizer Ltd has declared dividend of ₹35 - translating a dividend yield of 0.68%.

    Read More about Dividends

Pfizer Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Pfizer Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Pfizer Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Pfizer Ltd shares.

Pfizer Ltd (PFIZER) share price today is ₹5131.3

Pfizer Ltd is listed on NSE

Pfizer Ltd is listed on BSE

  • Today’s highest price of Pfizer Ltd is ₹5210.65.
  • Today’s lowest price of Pfizer Ltd is ₹5100.

Today’s traded volume of Pfizer Ltd(PFIZER) is 10.11K.

Today’s market capitalisation of Pfizer Ltd(PFIZER) is ₹23690.69Cr.

Pfizer Ltd(PFIZERPrice
52 Week High
₹6451.15
52 Week Low
₹3950

Pfizer Ltd(PFIZER) share price is ₹5131.3. It is down -20.46% from its 52 Week High price of ₹6451.15

Pfizer Ltd(PFIZER) share price is ₹5131.3. It is up 29.91% from its 52 Week Low price of ₹3950

Pfizer Ltd(PFIZERReturns
1 Day Returns
-47.25%
1 Month Returns
-7.49%
3 Month Returns
-13.34%
1 Year Returns
28.3%